Civic Intelligence

Grace Science Foundation

990 • Fiscal year 2016 • EIN 46-5727883

Jan 01, 2016 to Dec 31, 2016 • Filed on May 12, 2017

Organization ProfileWWW.GRACESCIENCE.ORG
235 Kansas Street Suite 200San Francisco, CA 94103

(415) 255-7666

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

14th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Liabilities / Revenue

14th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Net Margin

8th percentile

-45%

Higher net margin than 8% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Top Officer Pay

35th percentile

$0

Higher top officer pay than 35% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Asset Growth

8th percentile

-17%

Faster asset growth than 8% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2015 to 2016

Revenue Growth

4th percentile

-62%

Faster revenue growth than 4% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2015 to 2016

Balance Sheet
Liabilities / Assets14th percentile

Assets

Down

$1,336,131

Down $269,683 (-17%) from 2015

Net Assets

Down

$1,336,131

Down $269,683 (-17%) from 2015

Liabilities

Flat

$0

Flat from 2015

Revenue And Expenses
Liabilities / Revenue14th percentileNet Margin8th percentile

Revenue

Down

$600,124

Down $960,257 (-62%) from 2015

Expenses

Up

$869,807

Up $311,462 (+56%) from 2015

Net Income

Down

-$269,683

Down $1,271,719 (-127%) from 2015

Historical Trend

Balance Sheet Trend

Asset Growth8th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$4.0M$3.0M$2.0M$1.0M$0Assets 2014: $603,778Liabilities 2014: $0Net Assets 2014: $603,7782014Assets 2015: $1,605,814Liabilities 2015: $0Net Assets 2015: $1,605,8142015Assets 2016: $1,336,131Liabilities 2016: $0Net Assets 2016: $1,336,1312016Assets 2017: $2,109,224Liabilities 2017: $16,500Net Assets 2017: $2,092,7242017Assets 2018: $2,196,374Liabilities 2018: $0Net Assets 2018: $2,196,3742018Assets 2019: $2,889,615Liabilities 2019: $2,201Net Assets 2019: $2,887,4142019Assets 2020: $2,884,506Liabilities 2020: $386Net Assets 2020: $2,884,1202020Assets 2021: $3,128,030Liabilities 2021: $29,929Net Assets 2021: $3,098,1012021Assets 2022: $3,183,591Liabilities 2022: $51,224Net Assets 2022: $3,132,3672022Assets 2023: $2,790,274Liabilities 2023: $42,997Net Assets 2023: $2,747,2772023Assets 2024: $2,224,370Liabilities 2024: $1,004Net Assets 2024: $2,223,3662024

Highlighted filing

2016

Assets$1,336,131
Liabilities$0
Net Assets$1,336,131
Open 2016 Filing

Operations Trend

Revenue Growth4th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$2.0M$1.0M$0-$1.0MRevenue 2014: $664,490Expenses 2014: $60,712Net Income 2014: $603,7782014Revenue 2015: $1,560,381Expenses 2015: $558,345Net Income 2015: $1,002,0362015Revenue 2016: $600,124Expenses 2016: $869,807Net Income 2016: -$269,6832016Revenue 2017: $1,677,107Expenses 2017: $920,514Net Income 2017: $756,5932017Revenue 2018: $1,199,988Expenses 2018: $1,074,064Net Income 2018: $125,9242018Revenue 2019: $1,561,302Expenses 2019: $839,395Net Income 2019: $721,9072019Revenue 2020: $1,454,180Expenses 2020: $1,452,901Net Income 2020: $1,2792020Revenue 2021: $1,327,113Expenses 2021: $1,113,132Net Income 2021: $213,9812021Revenue 2022: $1,236,228Expenses 2022: $1,218,482Net Income 2022: $17,7462022Revenue 2023: $826,626Expenses 2023: $1,289,174Net Income 2023: -$462,5482023Revenue 2024: $943,011Expenses 2024: $1,519,386Net Income 2024: -$576,3752024

Highlighted filing

2016

Revenue$600,124
Expenses$869,807
Net Income-$269,683
Open 2016 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
May 12, 2017
Return Version
2016v3.0
Gross Receipts
$600,124
Mission and Program Overview

Mission

The mission of the foundation is to support and fund the development of life-saving treatment for patients that are deficient in the n-glycanese enzyme and those suffering from related genetic diseases. The activities of the foundation will involve providing grant funding to hospitals and medical resesarch facilities which are conducting medical research in various fields relating to the search for understnading and treatment of this condition, fostering collaboration between academia, research institutions, hospitals, private companies, and governmental agencies.

The mission of the foundation is to support and fund the development of life-saving treatment for patients that are deficient in the n-glycanese enzyme and those suffering from related genetic diseases.

Balance Sheet Detail
LineBeginningEndChange
Assets
Rtn Earn Endowment Incm Other Fnds$1,605,814$1,336,131▼ $269,683
Cash and Non-Interest-Bearing Accounts$1,605,814$1,336,006▼ $269,808
Accounts Receivable-$125-
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$1,605,814$1,336,131▼ $269,683
Liabilities
Total Liabilities$0$0→ $0
Net Assets / Fund Balance
Total Net Assets Fund Balance$1,605,814$1,336,131▼ $269,683
Total Liabilities and Net Assets / Fund Balance$1,605,814$1,336,131▼ $269,683
Compensation and Service Providers
Top Officer Pay35th percentile

Board Members and Trustees

NameTitle
Matthew WilseyPresident
Chelsea ClintonDirector
Elle StephensDirector
J Taylor CrandallDirector
Pete BrigerDirector
Egon DurbanChief Financial Officer
Dr Ken DrazanSecretary
Revenue and Support

Revenue Composition

Contributions and Grants
$600,124
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$600,124
Change in Net Assets
$-269,683
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$612,814
Other Expenses$255,746
Salaries, Compensation, and Employee Benefits$1,247
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$612,814--$612,814
Fees for Services Other-$77,050-$77,050
Advertising-$62,207-$62,207
Conferences and Meetings$43,727$3,290-$47,017
Fees for Services Legal-$27,760-$27,760
Travel$17,265$389-$17,654
Office Expenses$192$9,047-$9,239
Fees for Services Accounting-$5,750-$5,750
Other Salaries and Wages-$974-$974
Insurance-$401-$401
Payroll Taxes-$273-$273
Other Expenses$5$160-$160
Total Functional Expenses$674,003$195,804$0$869,807
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Gladstone InstitutePalo Alto, CA501(c)(3)Stem Cell Generation and Analysis$125,416
The Jackson LaboratoryBar Harbor, ME501(c)(3)Mouse Research$108,170
LUCILE PACKARD FOUNDATION FOR CHILDREN'S HEALTHPalo Alto, CA501(c)(3)Stem Cell Generation and Analysis$104,000
TEXAS CHILDREN'S HOSPITALHouston, TX501(c)(3)Fly Research$89,273
Perlstein Lab PbcS San Francisco, CA501(c)(3)Fly Natural History Study$60,000
Stanford UniversityPalo Alto, CA501(c)(3)STUDYING NGLY1'S CONNECTION WITH TRANSCRIPTION FACTOR$50,000
Virginia Commonwealth UniversityBx Richmond, VA501(c)(3)STUDYING NGLY1'S CONNECTION WITH TRANSCRIPTION FACTOR$37,955
American Foundation for the University of British ColumbiaWashington, DC-Read Through Drug Discovery Research$23,000
Retrophin IncSan Diego, CA-Assay Development & Small Molecule Development$15,000
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 2

“The president of the foundation has immaterial ownership interest, in the investments of fortress and silver lake, which are managed by two of the directors.”

Form 990, Part VI, Section A, Line 7A

“The president of the foundation has authority to elect one or more members of the governing body.”

Form 990, Part VI, Section A, Line 8B

“The foundation does not have any committees.”

Form 990, Part VI, Section B, Line 11B

“Prior to filing from 990, the foundation's president will review the form.”

Form 990, Part VI, Section B, Line 12C

“New board members are required to complete a conflicts of interest policy and self report any changes that may present a conflict.”

Form 990, Part VI, Section C, Line 18

“AVAILABLE UPON REQUEST.”

Form 990, Part VI, Section C, Line 19

“AVAILABLE UPON REQUEST.”

Filing and Contact Details

Filer

Filer Name
Grace Science Foundation
EIN
46-5727883
Phone
4152557666
Address
235 KANSAS STREET SUITE 200, SAN FRANCISCO, CA 94103

Signing Officer

Name
Matthew R Wilsey
Title
President
Phone
4152557666
Signed
2017-05-12
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Matthew R Wilsey
Formed
2014
Legal Domicile
CA
Voting Board Members
7
Independent Board Members
7
Employees
1
Volunteers
5

Preparer

Firm
Oum & Co Llp
Address
601 CALIFORNIA STREET SUITE 1800, SAN FRANCISCO, CA 94108
Preparer
Bradford Weisert
Phone
4154343744
Raw XML AppendixShowing 400 of 457 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsReceivableGrp/EOYAmt0125
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0THE MISSION OF THE FOUNDATION IS TO SUPPORT AND FUND THE DEVELOPMENT OF LIFE-SAVING TREATMENT FOR PATIENTS THAT ARE DEFICIENT IN THE N-GLYCANESE ENZYME AND THOSE SUFFERING FROM RELATED GENETIC DISEASES.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt062207
IRS990/AdvertisingGrp/TotalAmt062207
IRS990/AllOtherContributionsAmt0600124
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0GRACE SCIENCE FOUNDATION
IRS990/BooksInCareOfDetail/PhoneNum04152557666
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0235 KANSAS STREET SUITE 200
IRS990/BooksInCareOfDetail/USAddress/CityNm0SAN FRANCISCO
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd094103
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt01605814
IRS990/CashNonInterestBearingGrp/EOYAmt01336006
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt03290
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt043727
IRS990/ConferencesMeetingsGrp/TotalAmt047017
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0600124
IRS990/CYGrantsAndSimilarPaidAmt0612814
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt0255746
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-269683
IRS990/CYSalariesCompEmpBnftPaidAmt01247
IRS990/CYTotalExpensesAmt0869807
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0600124
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0GLADSTONE INSTITUTE - THE GOALS OF THE PROJECT WERE TO GENERATE IPSC LINES FROM A NGLY1 FAMILY WITH ISOGENIC CONTROLS AND TO FIND CELLULAR PHENOTYPES OF NGLY1 DEFICIENCY. OVER 2016, THE TEAM RAN INTO A CRITICAL ROADBLOCK REGARDING MAINTENANCE OF PATIENT-DERIVED IPSCS, PARTICULARLY REGARDING INSTABILITY OF CELLS OVER SUBSEQUENT PASSAGES. THE TEAM GENERATED NEW IPS CELL LINES FROM THE AFFECTED FAMILY AND 2ND PATIENT FAMILY TO OBTAIN STABLE PATIENT AND ISOGENIC CONTROL CELL LINES, AS WELL AS DETERMINE WHETHER INSTABILITY OF CELLS IS A PHENOTYPE OF NGLY1 DEFICIENCY. IN ADDITION, THEY GENERATED ISOGENIC CONTROL CELL LINES USING BOTH CRISPR/CA9 GENOME EDITING AND CRISPR IN WILD TYPE IPSCS TO ISOLATE PHENOTYPE OF DISEASE. FINALLY, THEY BEGAN OPTIMIZING HEPATIC DIFFERENTIATION AND LIVER BUD GENERATION.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt01
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0140713
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt05750
IRS990/FeesForServicesAccountingGrp/TotalAmt05750
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt027760
IRS990/FeesForServicesLegalGrp/TotalAmt027760
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt077050
IRS990/FeesForServicesOtherGrp/TotalAmt077050
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/PersonNm0MATTHEW WILSEY
IRS990/Form990PartVIISectionAGrp/PersonNm1EGON DURBAN
IRS990/Form990PartVIISectionAGrp/PersonNm2DR KEN DRAZAN
IRS990/Form990PartVIISectionAGrp/PersonNm3PETE BRIGER
IRS990/Form990PartVIISectionAGrp/PersonNm4CHELSEA CLINTON
IRS990/Form990PartVIISectionAGrp/PersonNm5J TAYLOR CRANDALL
IRS990/Form990PartVIISectionAGrp/PersonNm6ELLE STEPHENS
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1CHIEF FINANCIAL OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd00
IRS990/FormationYr02014
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantAmt0125416
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0612814
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0612814
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt0600124
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt07
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt0401
IRS990/InsuranceGrp/TotalAmt0401
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt08
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd00
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF THE FOUNDATION IS TO SUPPORT AND FUND THE DEVELOPMENT OF LIFE-SAVING TREATMENT FOR PATIENTS THAT ARE DEFICIENT IN THE N-GLYCANESE ENZYME AND THOSE SUFFERING FROM RELATED GENETIC DISEASES. THE ACTIVITIES OF THE FOUNDATION WILL INVOLVE PROVIDING GRANT FUNDING TO HOSPITALS AND MEDICAL RESEARCH FACILITIES WHICH ARE CONDUCTING MEDICAL RESEARCH IN VARIOUS FIELDS RELATING TO THE SEARCH FOR UNDERSTANDING AND TREATMENT OF THIS CONDITION, AND FOSTERING COLLABORATION BETWEEN ACADEMIA, RESEARCH INSTITUTIONS, HOSPITALS, PRIVATE COMPANIES, AND GOVERNMENTAL AGENCIES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt01605814
IRS990/NetAssetsOrFundBalancesEOYAmt01336131
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt09047
IRS990/OfficeExpensesGrp/ProgramServicesAmt0192
IRS990/OfficeExpensesGrp/TotalAmt09239
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0MISCELLANEOUS EXPENSES
IRS990/OtherExpensesGrp/Desc1PHOTOGRAPHY
IRS990/OtherExpensesGrp/Desc2OTHER FEES (BANK, CREDI
IRS990/OtherExpensesGrp/Desc3FILING FEES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt07044
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt1875
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt2584
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt3160
IRS990/OtherExpensesGrp/ProgramServicesAmt05
IRS990/OtherExpensesGrp/TotalAmt07044
IRS990/OtherExpensesGrp/TotalAmt1875
IRS990/OtherExpensesGrp/TotalAmt2589
IRS990/OtherExpensesGrp/TotalAmt3160
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0974
IRS990/OtherSalariesAndWagesGrp/TotalAmt0974
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt0273
IRS990/PayrollTaxesGrp/TotalAmt0273
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0MATTHEW R WILSEY
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0LUCILE PACKARD FOUNDATION FOR CHILDREN'S HEALTH - PRIMARY GOAL FOR THIS PROJECT IS TO STUDY NGLY1 DEFICIENCY USING INDUCED PLURIPOTENT STEM CELLS (IPSC) AS A TOOL. IN THE PAST, THIS GROUP HAS DERIVED IPSC LINES FROM FIBROBLAST CELLS WITH DIFFERENT NGLY1 MUTATIONS. ONE OF OUR MAJOR GOALS IS TO BETTER UNDERSTAND THE EFFECT OF NGLY1 DEFICIENCY DURING DISEASE DEVELOPMENT, ESPECIALLY IN THE DELAYED NEURAL DEVELOPMENT. 2015 WAS FOCUSED ON EXPANDING THE IPSC LINES AND DIFFERENTIATING THEM INTO NEURAL PROGENITOR CELLS. 2016 WAS DOING DETAILED OMICS PROFILING ON THE CELLS LINES. THE TEAM HAS FOUND INTERESTING PATHWAYS AND DRUG TARGETS VIA THIS RESEARCH. THEY HAVE ALSO SEEN CONNECTIONS WITH OTHER DISEASES THAT COULD HELP MANY PEOPLE IN ADDITION TO SPEEDING UP A TREATMENT FOR NGLY1 DEFICIENCY.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0119297
IRS990/ProgSrvcAccomActy2Grp/GrantAmt0104000
IRS990/ProgSrvcAccomActy3Grp/Desc0THE JACKSON LABORATORY - USING CRISPR TECHNOLOGIES THE JACKSON LABORATORY HAS CREATED THREE MUTATIONS, TWO THAT REPRESENT THE ALLELES A NGLY1 PATIENT AS WELL AS AN OUT OF FRAME NULL MUTATION. THE OUT OF FRAME NULL MUTATION IS A BY-PRODUCT OF THE CREATING THE KNOCK IN MUTATION. WHILE A COLLABORATOR IN JAPAN HAS MADE AN ENGASE KNOCK OUT ALLELE AVAILABLE FROM A REPOSITORY, THE COST TO PROCURE AND SHIP MICE TO THE U.S. IS GREAT AND THE MTAS REQUIRED TO PROCURE THE MICE ARE TIME CONSUMING AS TECH TRANSFER OFFICES NEGOTIATE TERMS. FOR EASE OF USE TO THE SCIENTIFIC COMMUNITY, WE HAVE USED CRISPR TECHNOLOGY TO GENERATE AN ADDITIONAL ENGASE KO MICE. THE ADVANTAGES OF HAVING THE ADDITIONAL JAX ALLELE ARE THAT NO MTAS ARE REQUIRED FOR DISTRIBUTION AND IT IS ALSO ON A PURE B6 GENETIC BACKGROUND. FINALLY, THE TEAM HAS ALSO MADE A CONDITIONAL KNOCK OUT MODEL THAT SHOULD BE QUITE USEFUL TO THE BROADER RESEARCH COMMUNITY IN 2017.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0115467
IRS990/ProgSrvcAccomActy3Grp/GrantAmt0100170
IRS990/ProgSrvcAccomActyOtherGrp/Desc0TEXAS CHILDREN'S HOSPITAL - DETERMINED THE EFFECT OF THE R402 DELETION ON THE STABILITY AND FUNCTION OF NGLY1. THE TEAM ALSO DETERMINED THE MECHANISM UNDERLYING THE PNGL MUTANT PHENOTYPES IN FLIES. FINALLY, THE RESEARCHERS IDENTIFIED GENETIC MODIFIERS OF THE PNGL PHENOTYPES IN FLIES.
IRS990/ProgSrvcAccomActyOtherGrp/Desc1PERLSTEIN LAB PBC - DEVELOPED A DROSOPHILA-BASED HIGH-THROUGHPUT DRUG SCREENFOR NGLY1. THEY OVERCAME TWO PERSISTENT CHALLENGES THROUGHOUT THE OPTIMIZATION PROCESS, SO INPARALLEL THEY PILOTED YEAST-TO-FLY SCREENING APPROACH TO IDENTIFY NOVEL EVOLUTIONARILY CONSERVEDCHEMICAL MODIFIERS OF NGLY1 DEFICIENCY. THEY ALSO PERFORMED A SCREEN WITH SEVERAL THOUSAND BIOACTIVE COMPOUNDS INCLUDING THE SET OF ALL FDA APPROVED DRUGS.
IRS990/ProgSrvcAccomActyOtherGrp/Desc2STANFORD UNIVERSITY - PRIMARY GOALS ARE TO IDENTIFY AND INVESTIGATE IMPORTANT NGLY1 SUBSTRATES. IN ADDITION, THEY ARE GENERATING AND CHARACTERIZING ZEBRAFISH MODELS.
IRS990/ProgSrvcAccomActyOtherGrp/Desc3OTHER PROGRAM SERVICES ARE RELATED TO RESEARCH AND DEVELOPMENT TO UNDERSTAND AND CURE RARE DISEASES BEGINNING WITH NGLY1 DEFICIENCY.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt089273
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt160000
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt250000
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt399253
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt089273
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt160000
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt250000
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt383955
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01560381
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0409865
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt0148480
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt01002036
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt0558345
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01560381
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-269683
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt01605814
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt01336131
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0GRACE SCIENCE FOUNDATION WAS FORMED ON MAY 19, 2014. 2016 IS THE FOUNDATION'S THIRD YEAR OF EXISTENCE.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0PART II, LINE 13
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0600124
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01560381
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0664490
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt02824995
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt02824995
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0600124
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01560381
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0664490
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt02824995
IRS990ScheduleA/TotalSupportAmt02824995
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt0125416
IRS990ScheduleI/RecipientTable/CashGrantAmt1104000
IRS990ScheduleI/RecipientTable/CashGrantAmt2108170
IRS990ScheduleI/RecipientTable/CashGrantAmt389273
IRS990ScheduleI/RecipientTable/CashGrantAmt460000
IRS990ScheduleI/RecipientTable/CashGrantAmt550000
IRS990ScheduleI/RecipientTable/CashGrantAmt637955
IRS990ScheduleI/RecipientTable/CashGrantAmt723000
IRS990ScheduleI/RecipientTable/CashGrantAmt815000
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc1501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc2501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc3501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc4501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc5501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc6501(C)(3)
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0STEM CELL GENERATION AND ANALYSIS
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1STEM CELL GENERATION AND ANALYSIS
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt2MOUSE RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt3FLY RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt4FLY NATURAL HISTORY STUDY
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt5STUDYING NGLY1'S CONNECTION WITH TRANSCRIPTION FACTOR
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt6STUDYING NGLY1'S CONNECTION WITH TRANSCRIPTION FACTOR
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt7READ THROUGH DRUG DISCOVERY RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt8ASSAY DEVELOPMENT & SMALL MOLECULE DEVELOPMENT
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0GLADSTONE INSTITUTE
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1LUCILE PACKARD FOUNDATION FOR CHILDREN'S HEALTH
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt2THE JACKSON LABORATORY
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt3TEXAS CHILDREN'S HOSPITAL
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt4PERLSTEIN LAB PBC
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt5STANFORD UNIVERSITY
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt6VIRGINIA COMMONWEALTH UNIVERSITY
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt7AMERICAN FOUNDATION FOR THE UNIVERSITY OF BRITISH COLUMBIA
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt8RETROPHIN INC
IRS990ScheduleI/RecipientTable/RecipientEIN0237203666
IRS990ScheduleI/RecipientTable/RecipientEIN1770440090
IRS990ScheduleI/RecipientTable/RecipientEIN2010211513
IRS990ScheduleI/RecipientTable/RecipientEIN3741100555
IRS990ScheduleI/RecipientTable/RecipientEIN4941156365
IRS990ScheduleI/RecipientTable/RecipientEIN5546001758
IRS990ScheduleI/RecipientTable/RecipientEIN6521559117
IRS990ScheduleI/RecipientTable/RecipientEIN7274842691
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt01650 OWENS ST
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt1400 HAMILTON AVE 340
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt2600 MAIN STREET
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt36621 FANNIN STREET
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt46000 SHORELINE CT SUITE 204
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt53145 PORTER DRIVE
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt6800 E LEIGH ST STE 3200
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt71718 M ST NW
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt812255 EL CAMINO REAL SUITE 250
IRS990ScheduleI/RecipientTable/USAddress/CityNm0PALO ALTO
IRS990ScheduleI/RecipientTable/USAddress/CityNm1PALO ALTO
IRS990ScheduleI/RecipientTable/USAddress/CityNm2BAR HARBOR
IRS990ScheduleI/RecipientTable/USAddress/CityNm3HOUSTON
IRS990ScheduleI/RecipientTable/USAddress/CityNm4S SAN FRANCISCO
IRS990ScheduleI/RecipientTable/USAddress/CityNm5PALO ALTO
IRS990ScheduleI/RecipientTable/USAddress/CityNm6BX RICHMOND
IRS990ScheduleI/RecipientTable/USAddress/CityNm7WASHINGTON
IRS990ScheduleI/RecipientTable/USAddress/CityNm8SAN DIEGO
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0CA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1CA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd2ME
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd3TX
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd4CA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd5CA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd6VA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd7DC
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd8CA
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd094301
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd194301
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd204609
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd377030
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd494080
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd594304
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd623298
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd720036
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd892130
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0* BEFORE FUNDING A PRINCIPAL INVESTIGATOR, THE FOUNDATION REQUIRES A DETAILED PROPOSAL WITH OBJECTIVES AND MILESTONES * THE PROPOSALS ARE REVIEWED BY THE FOUNDATION AND SCIENTIFIC ADVISORY BOARD * THE PROPOSALS ARE OFTEN REVISED SEVERAL TIMES TO GET THE CORRECT FIT * ONCE FUNDED, EACH PRINCIPAL INVESTIGATOR SUBMITS A WRITTEN SUMMARY EVERY QUARTER * THIS UPDATE IS TWO TO THREE PAGES IN LENGTH * THE REPORTS DISCUSS PROGRESS, HIGHLIGHT ROADBLOCKS AND IDENTIFY WHERE THEY NEED HELP * THE FOUNDATION STEPS-IN WHERE APPROPRIATE TO MAKE SURE OBJECTIVES AND MILESTONES ARE MET * IN ADDITION TO QUARTERLY REPORTS, THE FOUNDATION HOLDS A MONTHLY CONFERENCE CALL WHERE TWO TO THREE PRINCIPAL INVESTIGATORS PRESENT THEIR LATEST WORK * BEYOND THE ABOVE TWO INITIATIVES, THE FOUNDATION HOLDS ONE TO TWO IN-PERSON MEETINGS PER YEAR * DR. KEVIN LEE (CHIEF SCIENTIFIC OFFICER), DR. SELINA DWIGHT (PROGRAM MANAGER), AND MATT WILSEY(PRESIDENT) CONTACT RESEARCHERS AND PRINCIPAL INVESTIGATORS ON A REGULAR BASIS VIA EMAIL, PHONE, OR ONE ON ONE MEETINGS THE PRESIDENT ENSURES THAT EVERY DOLLAR IS USED TO SUPPORT THE GRACE SCIENCE FOUNDATION'S MISSION.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0PART I, LINE 2:
IRS990ScheduleI/Total501c3OrgCnt07
IRS990ScheduleI/TotalOtherOrgCnt02
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE PRESIDENT OF THE FOUNDATION HAS IMMATERIAL OWNERSHIP INTEREST, IN THE INVESTMENTS OF FORTRESS AND SILVER LAKE, WHICH ARE MANAGED BY TWO OF THE DIRECTORS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE PRESIDENT OF THE FOUNDATION HAS AUTHORITY TO ELECT ONE OR MORE MEMBERS OF THE GOVERNING BODY.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE FOUNDATION DOES NOT HAVE ANY COMMITTEES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3PRIOR TO FILING FROM 990, THE FOUNDATION'S PRESIDENT WILL REVIEW THE FORM.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4NEW BOARD MEMBERS ARE REQUIRED TO COMPLETE A CONFLICTS OF INTEREST POLICY AND SELF REPORT ANY CHANGES THAT MAY PRESENT A CONFLICT.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5AVAILABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6AVAILABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION A, LINE 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION A, LINE 7A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION A, LINE 8B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART VI, SECTION B, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART VI, SECTION C, LINE 18
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PART VI, SECTION C, LINE 19
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToProxyTaxInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TempOrPermanentEndowmentsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt01605814
IRS990/TotalAssetsEOYAmt01336131
IRS990/TotalAssetsGrp/BOYAmt01605814
IRS990/TotalAssetsGrp/EOYAmt01336131
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt0600124
IRS990/TotalEmployeeCnt01
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt0195804
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0674003
IRS990/TotalFunctionalExpensesGrp/TotalAmt0869807
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt00
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt01605814
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt01336131
IRS990/TotalOtherCompensationAmt00
IRS990/TotalOtherProgSrvcExpenseAmt0298526
IRS990/TotalOtherProgSrvcGrantAmt0283228
IRS990/TotalProgramServiceExpensesAmt0674003
IRS990/TotalReportableCompFromOrgAmt00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2016 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$1,336,131
Liabilities
$0
Net assets
$1,336,131
Revenue
$600,124
Expenses
$869,807
Net income
-$269,683
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$2.22$0.00$2.22$0.94$1.52$0.58
2023Detailed filing. Detailed filing data is available for this year.$2.79$0.04$2.75$0.83$1.29$0.46
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.18$0.05$3.13$1.24$1.22$0.02
2021Detailed filing. Detailed filing data is available for this year.$3.13$0.03$3.10$1.33$1.11$0.21
2020Detailed filing. Detailed filing data is available for this year.$2.88$0.00$2.88$1.45$1.45$0.00
2019Detailed filing. Detailed filing data is available for this year.$2.89$0.00$2.89$1.56$0.84$0.72
2018Detailed filing. Detailed filing data is available for this year.$2.20$0.00$2.20$1.20$1.07$0.13
2017Detailed filing. Detailed filing data is available for this year.$2.11$0.02$2.09$1.68$0.92$0.76
2016Detailed filing. Detailed filing data is available for this year.$1.34$0.00$1.34$0.60$0.87$0.27
2015Summary only. Only limited summary data is available for this year.$1.61$0.00$1.61$1.56$0.56$1.00
2014Detailed filing. Detailed filing data is available for this year.$0.60$0.00$0.60$0.66$0.06$0.60